Stocks and Investing Stocks and Investing
Thu, March 16, 2023

Jonathan Wolleben Maintained (AURA) at Buy with Decreased Target to $25 on, Mar 16th, 2023


Published on 2024-10-28 02:17:38 - WOPRAI, Jonathan Wolleben
  Print publication without navigation


Jonathan Wolleben of JMP Securities, Maintained "Aura Biosciences, Inc." (AURA) at Buy with Decreased Target from $30 to $25 on, Mar 16th, 2023.

Jonathan, nor any peers, have made any analyst calls on AURA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources